Skip to main content

and
  1. Article

    Open Access

    APPaRENT 3: Asthma Patients’ and Physicians' Perspectives on the Burden and Management of Asthma in Seven Countries

    Asthma management is strongly dependent on physician and patient beliefs and perceptions about the disease and its long-term treatment. The APPaRENT 3 study was conducted to explore factors influencing treatme...

    Bhumika Aggarwal, Mohamed Al-Moamary, Riyad Allehebi, Ashraf Alzaabi in Advances in Therapy (2024)

  2. Article

    Open Access

    Exploring Clinical Remission in Moderate Asthma – Perspectives from Asia, the Middle East, and South America

    Clinical remission is a relatively new concept in asthma but recent research initiatives suggest it could be an ambitious and achievable therapeutic target for patients with asthma.

    Kittipong Maneechotesuwan, Bhumika Aggarwal, Gabriel Garcia in Pulmonary Therapy (2024)

  3. Article

    Open Access

    Association between Increased Risk of Pneumonia with ICS in COPD: A Continuous Variable Analysis of Patient Factors from the IMPACT Study

    Despite the proven benefits of inhaled corticosteroid (ICS)-containing triple therapy for chronic obstructive pulmonary disease (COPD), clinicians limit patient exposure to ICS due to the risk of pneumonia. Ho...

    Bhumika Aggarwal, Paul Jones, Alejandro Casas, Mauro Gomes in Pulmonary Therapy (2024)

  4. Article

    Open Access

    Delphi Consensus on Clinical Applications of GOLD 2023 Recommendations in COPD Management: How Aligned are Recommendations with Clinical Practice?

    The objective of this Delphi study was to understand and assess the level of consensus among respiratory experts on the clinical application of GOLD 2023 recommendations in management of patients with chronic ...

    Antonio Anzueto, Mark Cohen, Andres L. Echazarreta, Gehan Elassal in Pulmonary Therapy (2024)

  5. Article

    Open Access

    SABAs as Reliever Medications in Asthma Management: Evidence-Based Science

    The role of as-needed inhaled short-acting β2-agonists (SABAs) in the management of asthma has become a subject of debate due to differing opinions in the professional community relating to the use of SABAs. In t...

    Israel Amirav, Gabriel Garcia, Bao Khac Le, Paulina Barria, Gur Levy in Advances in Therapy (2023)

  6. Article

    Open Access

    Safety of SABA Monotherapy in Asthma Management: a Systematic Review and Meta-analysis

    Short-acting β2-agonist (SABA) reliever overuse is common in asthma, despite availability of inhaled corticosteroid (ICS)-based maintenance therapies, and may be associated with increased risk of adverse events (...

    Thitiwat Sriprasart, Grant Waterer, Gabriel Garcia, Adalberto Rubin in Advances in Therapy (2023)

  7. Article

    Open Access

    Asthma severity in four countries of Latin America

    In Latin America, there is scarce information about severe asthma (SA) according to the ERS/ATS 2014 criteria. This study aimed to compare the demographic, socio, clinical characteristics, treatment, and use o...

    Hugo Neffen, Felipe Moraes, Karynna Viana, Valentina Di Boscio in BMC Pulmonary Medicine (2019)